A three-component solid-phase synthesis of 3-aminoimidazo[1,2-a]azines

Tetrahedron Letters

Volumn 39, Issue 31, 1998, Pages 5469-5472

  Blackburn, Christopher ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOIMIDAZO[1,2 A]PYRAZINE; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CYCLIZATION; POLYMERIZATION; SOLID PHASE EXTRACTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 0032581650     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01113-7     Document Type: Article

References (27)

1. 1. For reviews see for example: (a) Thompson, L. A.; Ellman, J. A. Chem. Rev. 1996, 96, 555.
2. (b) Terret, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135.
3. (c) Lowe, G. Chem. Soc. Rev. 1995, 309.
4. 2. (a) Armstrong, R. W.; Brown, D. S.; Keating, T. A.; Tempest, P. A. in Combinatorial Chemistry Synthesis and Applications (Ed. Wilson, S. R., Czarnik, A. W.), p. 153 John Wiley and Sons, New York 1997.
5. (b) Armstrong, R. W.; Combs, A. P.; Tempest, P. A.; Brown, S. D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 123-131. Strocker, A. M.; Keating, T. A.; Tempest, P. A.; Armstrong, R. W. Tetrahedron Lett. 1996, 37, 1149.
6. (b) Armstrong, R. W.; Combs, A. P.; Tempest, P. A.; Brown, S. D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 123-131. Strocker, A. M.; Keating, T. A.; Tempest, P. A.; Armstrong, R. W. Tetrahedron Lett. 1996, 37, 1149.
7. 3. (a) Cao, X.; Moran, E .J.; Siev, D.; Lio, A.; Ohasi, C.; Mjalli, A. M. M. Bioorg. Med. Chem. Lett. 1995, 5, 2953.
8. (b) Short, K. M.; Ching, B. W.; Mjalli, A. M. M. Tetrahedron, 1997, 53, 6653.
9. 4. Wipf, P., Cunnigham, A. Tetrahedron Lett. 1995, 36, 7819.
10. 5. See for example, (a) Kiselyov, A.S., Armstrong, R.W. Tetrahedron Lett. 1997, 38, 6163.
11. (b) Gopalsamy, A., Pallai, P. V., Tetrahedron Lett. 1997, 38, 907.
12. 6. Blackburn, C., Fleming, P., Guan, B., Shiosaki, K., Tsai, S. Tetrahedron Lett. in press.
13. 7. Starrett, J. E., Montzka, T. A., Crosswell, A. R., Cavanagh, R. L. J. Med. Chem., 1989, 32, 2204.
14. 8. Sabalayrolles, C.; Cros, G. H.; Milhavet, J. C.; Rechenq, E.; Chapat, J. P.; Boucard, M.; Serrano, J. J.; McNeill, J.H. J. Med. Chem. 1984, 27, 206-212.
15. 9. Rival, Y.; Grassy, G.; Michel, G. Chem. Pharm. Bull. 1992, 40, 1170-1176.
16. 10. Fisher, M.H.; Lusi, A. J. Med. Chem. 1972, 15, 982.
17. 11. Abe, Y., Kayakiri, H., Satoh, S., Imoue, T., Sawada, Y., Imai, K., Inamura, N., Asano, M., Hatori, C., Katayama, A., Oku, T., Tanaka, H., J. Med. Chem. 1998, 41, 564.
18. 12. Trapani, G.; Franco, M.; Ricciardi, L.; Latrofa, A.; Genchi, G.; Sanna, E.; Tuveri, F.; Cagetti, E.; Biggio, G.; Liso, G. J. Med. Chem., 1997, 40, 3109-3118.
19. 13. (a) Kobayashi, S.; Ishitani, H.; Nagayama, S. Synthesis 1995, 1095.
20. (b) Makioka, Y.; Shindo, T.; Taniguchi, Y.; Takaki, K.; Fujiwara, Y. Synthesis 1995, 801.
21. + requires 343.1559).
22. + requires 296.1511).
23. 2 (1:1) The product was shown by LC-MS to be identical to 1a prepared by the solution phase method.
24. 17. Keating, T.A., Armstrong, R.W. J. Amer. Chem. Soc. 1996, 118, 2574.
25. 18. Martinez, J.; Laur, J. Synthesis 1982, 979.
26. -1 in the IR spectrum.
27. 20. Prepared from 3,4-dimethoxyphenethylamine by formulation (ethylformate) then dehydration by reaction with phosgene and triethylamine followed by chromatography on basic alumina.